Literature DB >> 8607191

Pure red cell aplasia induced by FK506.

S Suzuki1, Y Osaka, I Nakai, T Yasumura, Y Omori, N Yamagata, C Shimazaki, T Oka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8607191     DOI： 10.1097/00007890-199603150-00026

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  5 in total

1.  [Persistent anemia after kidney transplantation in a 36-year-old male patient-an unusual cause].

Authors:  M Mäske; M Haubitz; S Graf; G Köhler; P Kostrewa; P Benöhr
Journal:  Internist (Berl)       Date:  2021-03       Impact factor: 0.743

2.  Bone marrow hypoplasia complicating tacrolimus (FK506) therapy.

Authors:  Annamaria Nosari; Laura Marbello; Luciano G De Carlis; Andrea De Gasperi; Giuliana Muti; Valentina Mancini; Enrica Morra
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

3.  Association of long-term tacrolimus (FK506) therapy with abnormal megakaryocytosis, bone marrow fibrosis, and dyserythropoiesis.

Authors:  Zhongbo Yang; Thomas Loew; Richard D Hammer
Journal:  Clin Case Rep       Date:  2015-06-13

4.  Post renal transplant pure red cell aplasia-is tacrolimus a culprit?

Authors:  Malagouda R Patil; Arpita Roy Choudhury; Manong Chohwanglim; Smita Divyaveer; Chetan Mahajan; Rajendra Pandey
Journal:  Clin Kidney J       Date:  2016-05-24

5.  Post renal transplant anemia: severity, causes and their association with graft and patient survival.

Authors:  Amir Schechter; Anat Gafter-Gvili; Daniel Shepshelovich; Ruth Rahamimov; Uzi Gafter; Eytan Mor; Avry Chagnac; Benaya Rozen-Zvi
Journal:  BMC Nephrol       Date:  2019-02-13       Impact factor: 2.388
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.